Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
24 studies found for:    fluorocholine
Show Display Options
Rank Status Study
1 Completed
Has Results
Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: IV administration of fluorine-18 fluorocholine followed by PET/CT imaging
2 Recruiting Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Other: F-18-FCH & Ga-68-NODAGA-MJ9
3 Recruiting Assessing 18F-Fluorocholine (18F-FCH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas
Condition: Brain Cancer
Interventions: Device: PET scan;   Radiation: 18F-Fluorocholine (18F-FCH)
4 Unknown  [18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes Metastases
Condition: Prostate Cancer
Intervention: Procedure: [18F] Fluorocholine PET/CT
5 Completed Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography
Condition: Prostate Cancer
Intervention: Device: Fluourine-18 Fluoromethylcholine PET/CT Imaging
6 Completed Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: 18F-Fluorocholine PET/CT
7 Active, not recruiting 18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases
Condition: Brain Metastases
Intervention: Procedure: 18F-FCH PET Scan
8 Not yet recruiting Combined Fluorocholine Positron Emission Tomography and Magnetic Resonance Imaging (FCH-PET/MRI) in Curative Treatment of a Hepatocellular Carcinoma
Condition: Patients Eligible to a Curative Treatment for Primary HCC
Intervention: Device: PET/MRI system (SIEMENS AG, Munich, Germany; distributed in France by SIEMENS S.A.S, Saint-Denis, France)
9 Recruiting F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer
Condition: Prostate Cancer
10 Unknown  The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate Cancer
Condition: Prostate Cancer
11 Active, not recruiting Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis
Conditions: Breast Cancer Diagnosis;   Positron Emission Tomography;   Magnetic Resonance Imaging
Interventions: Drug: 18F-FCH;   Drug: Magnevist
12 Recruiting Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
Condition: Carcinoma, Hepatocellular
Interventions: Other: FDG Positron Emission Tomography;   Other: FCH Positron Emission Tomography
13 Recruiting Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement
Conditions: Erdheim-Chester Disease;   Langerhans Cell Histiocytosis;   Histiocytic Disorders
Interventions: Radiation: F-choline PET Scan;   Device: FDG-PET;   Procedure: biopsy
14 Completed 18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Fluorocholine (18F-FCH) Injection;   Radiation: PET scan;   Radiation: Whole body MRI
15 Not yet recruiting Localization of Parathyroid Adenoma by Fluorocholine PET/MRI (Positron Emission Tomography -MRI)
Condition: Primary Hyperthyroidism
Interventions: Device: PET-MR;   Device: PET-CT
16 Completed Multimodal Diagnostic Assessment of Cerebral Gliomas With FET & FCH PET/CT, and Magnetic Resonance Imaging/Spectroscopy
Condition: Glioma
17 Unknown  To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Disease
Interventions: Drug: 18F- fluorocholine;   Drug: 18F- fluorodeoxyglucose
18 Active, not recruiting 18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Other: [F-18]-FCH;   Radiation: PET scan;   Radiation: MRI scan
19 Recruiting Genomic and Imaging Study for Patients Undergoing Surgery for Liver Cancer
Condition: Liver Cancer
Intervention: Drug: Fluoromethylcholine (FCH) PET/CT Imaging
20 Recruiting PET/MRI for Men Being Considered for Radiotherapy for Suspected Prostate Cancer Recurrence Post-Prostatectomy
Condition: Prostate Cancer
Intervention: Device: 18F-FCH PET/MRI Scan

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.